Locations:
Search
Seven-gene biosignature becomes first effective means to reduce over- and under-treatment with radiation therapy
Rare cancer presents as unresolved changes of the nipple
Retrospective study involves 18 years of follow-up and shows low risk of local recurrence.
Use of tool can change recommendation to add or omit radiation
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Tumor genomics offer clues for identifying high risk of relapse
Multi-center study indicates benefit is associated with risk stratification and the utilization of radiation therapy
Novel assay identifies women most likely to benefit
Advertisement
Advertisement